ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

Teddy DeVita’s Courageous Fight Ends At Age 17

June 6, 1980

New research Suggested For Immunobiology

November 18, 1977

CTEP Deploys Website To Track Trial Activation

December 10, 2010

In Brief: Gertrude Elion, Nobel Laureae Whose Work Led To New Drugs For Cancer, Dead at 81

February 26, 1999

SBIR: A Sure Fire Way to Get Funded In A Year When Applications Scoring Over 158 Are Being Dropped

February 22, 1985